December 13th, 2011, by David Pascoe | in the news, new treatments, sansrosa
The Daily Mail continues its interest in rosacea treatments with an article about an unnamed glaucoma treatment that has been formulated as a gel treatment for the redness of rosacea. Of course we know this treatment as Sansrosa. Other names we have seen over the years include COL-118 and CD07805/47. The active ingredient in the glaucoma treatment of mentioned …
November 21st, 2011, by David Pascoe | in the news, new treatments
The FDA announced today that the U.S. Food and Drug Administration approved 35 new medicines in fiscal year 2011. They included “important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; …
October 14th, 2011, by David Pascoe | clinical trials, new treatments, red face
A product from Merck designated as MK-0524, also known as Laropiprant, is to be trialled as a treatment for the redness of rosacea. This is great news for rosacea …
July 20th, 2011, by David Pascoe | aczone, in the news, new treatments, oxymetazoline
News today that Allergan are buying the privately held pharmaceutical company Vicept Therapuetics. The aim of many small startup companies is to be acquired by a larger company, Vicept telling us that “We believe Allergan …
June 28th, 2011, by David Pascoe | new treatments
The Pharmaceutical Research and Manufacturers of America tells us that there are currently 9 drugs in development for rosacea. I was initially curious as to how counted nine. Read on if you want to see how they get to this number. 277 Medicines in Development For Skin Diseases Washington, D.C. (June 13, 2011) — America’s biopharmaceutical …
